RE
NASDAQ · REPH
Recro Pharma, Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
$2.09
Down-$0.01 (-0.48%)
Updated Oct 10, 2026, 7:07 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 177.42M
- P/E ratio
- -7.89
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 137.54K
- Avg. volume
- 128.49K
Price performance · REPH
REPH price history
1M range · 0 trading sessions · Daily adjusted prices
REPH does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest REPH news
The latest Smart Investors Daily articles mentioning REPH.
Stock researchCompany · Financials
Company
Market Activity
Research & News
Loading stock research…
